Today, Lightship and Circuit Clinical proudly announce their strategic merger, forming a leading, unified force in clinical trial delivery. This landmark collaboration represents a significant step toward consolidating a fragmented industry—establishing a new standard for scale, accessibility, and innovation.
By uniting complementary capabilities, deep therapeutic expertise, and cutting-edge delivery models, the combined organization is purpose-built for growth and long-term impact. Bringing together Lightship’s leadership in hybrid trial models and mobile care with Circuit Clinical’s trusted community-based site network and patient engagement strengths, the new entity offers an integrated solution for sponsors, CROs, healthcare systems, and—above all—patients. Together, they are uniquely positioned to expand access, accelerate timelines, and enhance the overall clinical trial experience.
“Together, we’re redefining what’s possible in clinical research,” said David MacMurchy, CEO of Lightship. “This is an exciting milestone for our teams and for the industry as a whole. Together, we will reframe what’s possible in clinical research—delivering greater value to sponsors and better outcomes for patients everywhere.”
“This merger is more than a business combination; it’s a bold response to the evolving needs of clinical research,” said Dr. Irfan Khan, CEO of Circuit Clinical. “Lightship plus Circuit Clinical delivers the scale, trust, and innovation needed to meet the growing complexity of modern trials.”
Strategic Highlights of the Merger:
- Expanded Reach through physical site networks and remote delivery capabilities
- Flexible Participation Models supporting traditional, hybrid, and fully virtual trials
- Scalable, Professionally Managed Infrastructure that simplifies execution and accelerates patient enrollment
- Streamlined Services that enhance the experience for investigators, health systems, sponsors, and CROs
By combining proven delivery models with top-tier operational talent, the merged company is setting a new bar for the future of clinical trials.
Mr. MacMurchy and Dr. Khan will serve as co-CEOs of the new organization. Both Circuit Clinical and Lightship will continue to operate under their existing brands during the transition. The combined company’s new name and identity will be announced in the coming weeks.
Explore AITechPark for the latest advancements in AI, IOT, Cybersecurity, AITech News, and insightful updates from industry experts!